Stocks News

LAST PRICE
274.6700
TODAY'S CHANGE (%)
Trending Up0.4100 (0.1495%)

Bid / Lots
212.7600/ 1
Ask / Lots
299.9400/ 1
Open / Previous Close
274.2600 / 274.2600
Day Range
Low 272.2900
High 275.4200
52 Week Range
Low 204.4400
High 275.4200
Volume
333,292
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 16, 2024
- United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires
  4:41PM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/16/2024 (MT Newswires) -- Christopher Causey, Director, on May 15, 2024, sold 2,000 shares in United Therapeutics (UTHR) for $545,800. Following the Form 4 filing with the SEC, Causey has control over a total of 4,185 shares of the ...
May 14, 2024
- United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  4:39PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 10, 2024
- United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires
  4:41PM ET on Friday May 10, 2024 by MT Newswires
  Companies Mentioned: UTHR
  04:41 PM EDT, 05/10/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 08, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,898,393. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...
May 8, 2024
- United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  5:15PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:15 PM EDT, 05/08/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 07, 2024, sold 3,600 shares in United Therapeutics (UTHR) for $949,737. Following the Form 4 filing with the SEC, Rothblatt has control over a total ...
May 7, 2024
- United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing, from 5:00PM ET on Tuesday May 07, 2024 by MT Newswires
  5:00PM ET on Tuesday May 07, 2024 by MT Newswires
  Companies Mentioned: UTHR
  05:00 PM EDT, 05/07/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 03, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $1,871,233. Following the Form 4 filing with the SEC, Rothblatt has control over a tota...

May 17, 2024
- Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires
  4:17PM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: MEDP
- --Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires
  7:29AM ET on Friday May 17, 2024 by MT Newswires
  Companies Mentioned: BMRN
May 14, 2024
- Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  4:25PM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: MEDP
May 13, 2024
- Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires
  4:14PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: BMRN
- Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test, from 4:18AM ET on Monday May 13, 2024 by MT Newswires
  4:18AM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: QGEN
May 8, 2024
- Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours, from 4:58PM ET on Wednesday May 08, 2024 by MT Newswires
  4:58PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  4:54PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: MEDP
- -- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M, from 4:25PM ET on Wednesday May 08, 2024 by MT Newswires
  4:25PM ET on Wednesday May 08, 2024 by MT Newswires
  Companies Mentioned: EXAS
- Exact Sciences Announces First-Quarter 2024 Results, from 4:05PM ET on Wednesday May 08, 2024 by Business Wire
  4:05PM ET on Wednesday May 08, 2024 by Business Wire
  Companies Mentioned: EXAS
- BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV, from 8:01AM ET on Wednesday May 08, 2024 by PR Newswire
  8:01AM ET on Wednesday May 08, 2024 by PR Newswire
  Companies Mentioned: BMRN

United Therapeutics Corp
NASDAQ:UTHRUnited States

Search Criteria

May 16, 2024

United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing, from 4:41PM ET on Thursday May 16, 2024 by MT Newswires

May 14, 2024

United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing, from 4:39PM ET on Tuesday May 14, 2024 by MT Newswires

May 10, 2024

United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing, from 4:41PM ET on Friday May 10, 2024 by MT Newswires

May 8, 2024

United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing, from 5:15PM ET on Wednesday May 08, 2024 by MT Newswires

May 7, 2024

United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing, from 5:00PM ET on Tuesday May 07, 2024 by MT Newswires

Peers Headlines

May 17, 2024

Medpace Holdings Insider Sold Shares Worth $15,924,222, According to a Recent SEC Filing, from 4:17PM ET on Friday May 17, 2024 by MT Newswires

--Baird Downgrades BioMarin Pharmaceutical to Neutral From Outperform, Cuts Price Target to $72 From $104, from 7:29AM ET on Friday May 17, 2024 by MT Newswires

May 14, 2024

Medpace Holdings Insider Sold Shares Worth $1,996,723, According to a Recent SEC Filing, from 4:25PM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing, from 4:14PM ET on Monday May 13, 2024 by MT Newswires

Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test, from 4:18AM ET on Monday May 13, 2024 by MT Newswires

May 8, 2024

Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours, from 4:58PM ET on Wednesday May 08, 2024 by MT Newswires

Medpace Holdings Insider Sold Shares Worth $21,129,347, According to a Recent SEC Filing, from 4:54PM ET on Wednesday May 08, 2024 by MT Newswires

-- Earnings Flash (EXAS) EXACT SCIENCES Reports Q1 Revenue $637.5M, vs. Street Est of $626.8M, from 4:25PM ET on Wednesday May 08, 2024 by MT Newswires

Exact Sciences Announces First-Quarter 2024 Results, from 4:05PM ET on Wednesday May 08, 2024 by Business Wire

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV, from 8:01AM ET on Wednesday May 08, 2024 by PR Newswire